It is not yet clear when that national security investigation will end, and if and how tariffs on pharmaceuticals will be ...

A February executive order on pharmaceutical price transparency does nothing to change the incentives that keep costs opaque.

The U.S. Food and Drug Administration (FDA) already declared that shortages of popular GLP-1 medications have ended, CNN reported. Those medications include semaglutide (Ozempic and Wegovy) and ...

Thwarted in her ambition to become a brewmaster, Kiran Mazumdar-Shaw channeled her frustrations into building a knockoff drug ...

The issue is nothing new, but it has been receiving more attention as the Trump administration, lawmakers and community ...

his company would be transparent with consumers about the cost of tariffs and broker fees and pass them "directly" on to customers. There would be no way for Cost Plus Drugs to "eat" the costs.

"You can reclaim your health, but there are no such things as miracle pills." Kessler explores the weigh loss drug craze in his new book, "Diet, Drugs and Dopamine: The New Science of Achieving a ...

CEO Tara Comonte said the weight-loss program has no plans to shut down ... providers to assist in prescribing the trendy GLP-1 drugs semaglutide and tirzepatide, known by brand names Ozempic ...